Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

CYP2A22 Inhibitors

CYP2A22 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of CYP2A22, an enzyme belonging to the cytochrome P450 superfamily. CYP2A22 is involved in the oxidative metabolism of various endogenous and exogenous compounds, including the metabolism of certain lipids, hormones, and xenobiotics. As a member of the cytochrome P450 family, CYP2A22 is a monooxygenase enzyme that catalyzes the insertion of an oxygen atom into its substrates, a reaction critical for the detoxification and biotransformation processes within the liver and other tissues. The enzyme's role in metabolizing a range of substrates makes it a key player in maintaining the balance of various biochemical pathways, particularly those related to drug metabolism and the processing of potentially harmful compounds.

Inhibitors of CYP2A22 are typically small molecules that bind to the active site of the enzyme, blocking its ability to catalyze the monooxygenation of its substrates. These inhibitors may act by occupying the substrate-binding site, thus preventing the enzyme from interacting with its natural substrates, or by altering the enzyme's conformation in a way that diminishes its catalytic efficiency. The development of CYP2A22 inhibitors often involves detailed studies of the enzyme's structure, focusing on the identification of critical residues within the active site that are essential for substrate binding and catalysis. By inhibiting CYP2A22, researchers can gain insights into the enzyme's specific role in various metabolic processes and understand how the inhibition of this enzyme affects the overall metabolism of its substrates. The study of CYP2A22 inhibitors provides valuable information about the complex interplay between different cytochrome P450 enzymes and their collective influence on metabolic homeostasis. This research contributes to a broader understanding of the functional diversity within the cytochrome P450 family and the specific roles that individual enzymes play in regulating the metabolism of both endogenous and exogenous compounds.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

α-Naphthoflavone

604-59-1sc-257037
sc-257037A
sc-257037B
sc-257037C
1 g
5 g
25 g
100 g
$34.00
$46.00
$156.00
$500.00
3
(1)

α-Naphthoflavone is a direct inhibitor of CYP2A22, influencing its monooxygenase activity. This compound is known for its ability to modulate xenobiotic metabolism through inhibition of the P450 pathway.

Methoxsalen (8-Methoxypsoralen)

298-81-7sc-200505
1 g
$28.00
1
(1)

Methoxsalen is a direct inhibitor of CYP2A22, influencing its enzyme and heme binding activities. Its role in the epoxygenase P450 pathway and xenobiotic metabolism emphasizes its significance in cellular processes.

Tranylcypromine

13492-01-8sc-200572
sc-200572A
1 g
5 g
$175.00
$599.00
5
(1)

Tranylcypromine acts as a direct inhibitor of CYP2A22, affecting its enzyme binding and monooxygenase activities. Its influence on xenobiotic metabolic processes makes it a significant modulator of cellular functions.

Clopidogrel

113665-84-2sc-507403
1 g
$122.00
1
(0)

Clopidogrel acts as an indirect inhibitor of CYP2A22 by interfering with its enzyme binding activity. Its role in xenobiotic metabolism, particularly in drug interactions, highlights its clinical relevance.

Thio-TEPA

52-24-4sc-253693
1 g
$228.00
(0)

ThioTEPA is an indirect inhibitor of CYP2A22, potentially influencing xenobiotic metabolic processes. Its impact on cellular functions is relevant, particularly in the context of its chemotherapeutic applications.

Dicoumarol

66-76-2sc-205647
sc-205647A
500 mg
5 g
$20.00
$40.00
8
(1)

Dicoumarol acts as an indirect inhibitor of CYP2A22, potentially influencing its involvement in the coumarin metabolic process. Its impact on xenobiotic metabolism highlights its role in cellular responses.

Methysticin

495-85-2sc-205750
sc-205750A
5 mg
10 mg
$165.00
$225.00
(0)

Methysticin, a compound with potential inhibitory effects on CYP2A22, may indirectly modulate xenobiotic metabolic processes. Its impact on specific cellular pathways underscores its pharmacological relevance.